154
Participants
Start Date
March 5, 2017
Primary Completion Date
December 13, 2019
Study Completion Date
December 13, 2019
BFKB8488A
Administered subcutaneously starting on Day 1 and according to dosing schedule.
Placebo
Administered subcutaneously starting on Day 1 and according to dosing schedule.
Carolina Research Center at Jones Family Practice, Shelby
Agile Clinical Research Trials, Atlanta
MD Clinical, Hallandale
Premier Research Associate, Inc, Miami
Pinnacle Research Group Cullman, Anniston
Pinnacle Research Group; Llc, Central, Anniston
New Orleans Center for Clinical Research, Knoxville
MidWest Clinical Research, Overland Park
Dallas Diabetes & Endocrine Center, Dallas
Texas Clinical Research Institute, LLC, Arlington
Clinical Trials of Texas Incorporated, San Antonio
Consano Clinical Research, Shavano Park
Northeast Clinical Research of San Antonio LLC, San Antonio
Southern California Research Center, Inc., Coronado
Diabetes Research Center, Tustin
Stanford Health Care, Stanford
Hassman Research Institute, Berlin
inVentiv Health Clinical, Montreal
Lead Sponsor
Genentech, Inc.
INDUSTRY